Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

About 40% of U.S. adults suffer from obesity, and the cost of covering GLP-1 agonists and related anti-obesity drugs can be ...

Drug companies are under fire for the high cost of Ozempic and simlar meds. A doctor said patients who can't afford it may ...

A new study linked weight loss drugs known as semaglutides (Ozempic is one) to a lower risk of opioid overdoses. Doctors tell ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

Ozempic continues to surge in popularity for managing type 2 diabetes and off-label weight loss, but are there natural ...

Sima Sistani helped push the company into the GLP-1 drug space with the $106 million acquisition of Sequence.

Hundreds of Americans have jumped on a multi-state lawsuit alleging that the makers of Ozempic and Mounjaro caused ...

WeightWatchers CEO Sima Sistani, who pushed the company into embracing weight-loss drugs, is leaving the position after a two ...

(HealthDay News) — During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO Lars Fruergaard Jørgensen faced tough questions over the company’s high prices for its blockbuster ...

Sen. Bernie Sanders’ aggressive targeting of Danish drugmaker Novo Nordisk’s Ozempic and Wegovy pricing, and not Eli Lilly’s ...

It’s similar with multiple sclerosis. Actually, there are so many good drugs out there. A lot of the market has already been ...